Dr.. Kevin Roth, MD, currently chair of
pathology at the University of Alabama at Birmingham, has been named
chair of the Columbia's Department of Pathology & Cell Biology and
pathologist-in-chief at NewYork-Presbyterian, effective
September 1, 2015. Dr. Roth succeeds Michael Shelanski, MD, PhD, also a neuropathologist, following his 28-year tenure as chair of the department.
Although Dr. Shelanski is stepping down, his is remaining on staff at the department. Dr. Roth's addition will therefore bring to seven the number of neuropathologists practicing at Columbia, including Drs. Jim Goldman, Peter Canoll, Phyllis Faust, Jean-Paul Vonsattel, and Andy Teich.
Although Dr. Shelanski is stepping down, his is remaining on staff at the department. Dr. Roth's addition will therefore bring to seven the number of neuropathologists practicing at Columbia, including Drs. Jim Goldman, Peter Canoll, Phyllis Faust, Jean-Paul Vonsattel, and Andy Teich.
 |
| Kevin A. Roth, MD, PhD |
Dr. Roth’s professional training included a combined anatomic pathology and
neuropathology residency at Washington University in St. Louis, where he
was later appointed an assistant professor in the Department of
Pathology. Dr.
Roth rose through the faculty ranks to become a tenured professor in
the Departments of Pathology and Immunology and Molecular Biology and
Pharmacology there before moving to the University of Alabama at
Birmingham, where he was named chair of the Department
of Pathology in 2008.
Dr. Roth serves as president of the American Society for Investigative Pathology, chair of the Neural Oxidative Metabolism and Death (NOMD) Study Section,
and editor-in-chief of the American Journal of Pathology, which is devoted to elucidating the cellular and molecular mechanisms of disease pathogenesis.
No comments:
Post a Comment